Quanticate Adds New Leadership to Oversee Expansion in Clinical Data Management and Pharmacovigilance
Quanticate is please to announce the addition of Sally Du Toit as the VP of Pharmacovigilance and Chris Cramer as the VP of Clinical Data Management to our management team. As Quanticate continues to expand, we have seen the need to add additional experienced leadership to our Clinical Data Management and Pharmacovigilance groups. The addition of Sally and Chris will be of great importance in shaping our service as Quanticate continues to grow.
Sally Du Toit has joined Quanticate from her last role as Director of Pharmacovigilance at Aptiv Solutions, Sally has 27 years industry experience including experience as a Deputy QPPV. Sally has specific experience in device trials and post-market device vigilance, in addition to extensive experience in both clinical studies and post-marketing surveillance for drugs. Chris Cramer has joined Quanticate from PharmaNet, Chris was responsible for European data management operations. She brings over 25 years experience in the CRO and pharmaceutical industries and specific knowledge within late phase trials and electronic data capture solutions.
The full press release can be found here
